Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia-Reference-Cited by-同舟云学术

Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia

Published:2021-09-06 Issue:6 Volume:215 Page:245
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Chen Vivien M¹²^ORCID,Curnow Jennifer L³,Tran Huyen A⁴⁵^ORCID,Choi Philip Y‐I⁶^ORCID

Affiliation:

1. Concord Hospital Sydney NSW

2. ANZAC Research Institute University of Sydney Sydney NSW

3. Westmead Hospital Sydney NSW

4. Alfred Hospital Melbourne VIC

5. Central Clinical School Monash University Melbourne VIC

6. Canberra Hospital Canberra ACT

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.51229

Reference12 articles.

1. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

2. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

3. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

4. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

5. Medicines and Healthcare products Regulatory Agency.Coronavirus vaccine ‐ weekly summary of Yellow Card reporting updated 28 April 2021.https://www.gov.uk/government/publications/coronavirus‐covid‐19‐vaccine‐adverse‐reactions/coronavirus‐vaccine‐summary‐of‐yellow‐card‐reporting(viewed May 2021).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data;Vaccine;2024-03

2. Forensic Approach to Death as an Adverse Event Following Immunization;Reference Module in Social Sciences;2024

3. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines, and reporting;Management, Body Systems, and Case Studies in COVID-19;2024

4. Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation;Journal of Thrombosis and Haemostasis;2023-11

5. The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study;The Lancet Regional Health - Western Pacific;2023-11